UCB, Inc.
UCB, Inc.
1950 Lake Park Drive
Smyrna, Georgia 30080
Phone: (770) 970-7500Website: https://www.ucb-usa.com/Careers: careers.ucb.comPatient Assistance Program: www.ucb-usa.com/Patients/Patients
Latest news
- FDA Approves Bimzelx (bimekizumab-bkzx) for the Treatment of Adults with Moderate to Severe Plaque Psoriasis
18 October 2023 - FDA Approves Zilbrysq (zilucoplan) for the Treatment of Adults with Generalized Myasthenia Gravis
17 October 2023 - UCB Provides Update on U.S. Regulatory Review of Bimekizumab
19 September 2023 - FDA Approves Rystiggo (rozanolixizumab-noli) for the Treatment of Adults with Generalized Myasthenia Gravis
27 June 2023 - UCB Provides Update on U.S. FDA Review of the Biologics License Application for Bimekizumab
26 June 2023 - UCB Announces Rozanolixizumab BLA for the Treatment of Generalized Myasthenia Gravis Filed with U.S. FDA and Designated for Priority Review
6 January 2023 - UCB Announces U.S. FDA Acceptance of New Drug Application and EMA MAA Validation for Zilucoplan for the Treatment of Generalized Myasthenia Gravis in Adult Patients
14 November 2022 - Update on U.S. FDA Review of Biologics License Application (BLA) for Bimekizumab - Complete Response Letter
13 May 2022 - UCB Presents Efficacy and Safety Results for Zilucoplan and Rozanolixizumab in Generalized Myasthenia Gravis
10 May 2022 - UCB Announces Positive Data in Myasthenia Gravis with Zilucoplan Phase 3 Study Results
4 February 2022
Drugs Associated with UCB, Inc.
UCB, Inc. manufactures, markets and/or distributes more than 11 drugs in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.
| Brand/Generic Name | Reviews | Rating |
|---|---|---|
|
Bimzelx
Generic name: bimekizumab Drug class: interleukin inhibitors |
1 review | 9.0 / 10 |
|
Briviact
Generic name: brivaracetam Drug class: pyrrolidine anticonvulsants |
54 reviews | 6.4 / 10 |
|
Cimzia
Generic name: certolizumab Drug class: TNF alfa inhibitors |
81 reviews | 6.6 / 10 |
|
Fintepla
Generic name: fenfluramine Drug class: CNS stimulants, miscellaneous anticonvulsants |
||
|
Keppra
Generic name: levetiracetam Drug class: pyrrolidine anticonvulsants |
285 reviews | 5.7 / 10 |
|
Keppra XR
Generic name: levetiracetam Drug class: pyrrolidine anticonvulsants |
18 reviews | 7.2 / 10 |
|
Nayzilam
Generic name: midazolam Drug class: benzodiazepines |
1 review | 10 / 10 |
|
Neupro
Generic name: rotigotine Drug class: dopaminergic antiparkinsonism agents |
64 reviews | 7.7 / 10 |
|
Rystiggo
Generic name: rozanolixizumab Drug class: selective immunosuppressants |
1 review | 6.0 / 10 |
|
Vimpat
Generic name: lacosamide Drug class: miscellaneous anticonvulsants |
147 reviews | 6.7 / 10 |
|
Zilbrysq
Generic name: zilucoplan Drug class: selective immunosuppressants |
||
| For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). | ||
